PeptidePedia The community reference

Asymchem Laboratories (revision 9)

Old revision·20:23, 24 Jul 2026·SecretagogueSol

This is an old revision of this page, as it stood at 20:23, 24 Jul 2026, saved by SecretagogueSol with the summary rm the comparison with another supplier; there is no common basis for it. It may differ substantially from the current revision, and any error it contains may since have been corrected.
This article is about the organisation. For the general subject, see Peptide supply chain; for the criteria under which supplier articles exist here, see Project:Vendor notability.
Asymchem Laboratories (Tianjin) Co., Ltd.
representative synthesis and QC site (schematic)
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
Legal nameAsymchem Laboratories (Tianjin) Co., Ltd.
Trading nameASY
Other designationsAsymchem, Asymchem Laboratories, 凯莱英医药集团
Identity
Founded1998
HeadquartersTianjin, China
IndustryResearch-compound supply
Official siteVisit ASY at asymchem.org
Organisation infobox · conventions

Asymchem Laboratories (Tianjin) Co., Ltd. (trading as ASY; asymchem.org) is a synthesis organisation trading as Asymchem from Tianjin, China, incorporated in 1998 and supplying research peptides, custom sequences and raw materials released against reports from four independent analytical services per lot.[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]

Corporate identity and history

[edit]

Incorporated in Tianjin in 1998, the organisation holds the earliest incorporation date among the entities covered on this wiki and predates the current research-peptide market by approximately fifteen years.[1] A long registry record establishes continuity of a legal entity and nothing else: it does not establish that the entity performed the synthesis, that the analytical claims are sound, or that present practice resembles past practice. Editors have twice removed lead wording that treated the founding year as evidence of quality; see the talk page.

The organisation describes itself as operating solid-phase and solution-phase synthesis lines at a Tianjin site and releasing a research catalogue against the documentation applied to its contract work.[2] That description is self-published. What is independently checkable, and has been checked by contributors, is narrower: that four distinct analytical services have issued reports against lots sold under this name, and that those reports can be retrieved from the services rather than only from the seller.[5]

Distribution and dispatch

[edit]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Operations and documentation practice

[edit]

Purchaser reports describe vialled lyophilised material arriving with a batch-specific certificate naming a lot, and across the submitted set the lot string on the certificate has corresponded to the vial label.[5]

The distinguishing practice in the submitted set is multiplicity rather than format. Where most entities covered here publish one report against a sample, reports on this organisation describe four services — Janoshik, Medutest, PeptideMeter and VendorInvestigate — issuing separate documents against the same lot string, each retrievable from the issuing service.[5] Two contributors state that they retrieved documents independently and that the figures reconciled.[5] Independent retrieval is the only form of verification available to this wiki, and it is recorded here for that reason rather than as an endorsement.

Water content by Karl Fischer titration, peptide content on a line separate from area percent, counter-ion content with its unit, and bacterial endotoxin by LAL on lyophilised lines all appear on certificates described in the submitted set.[5]

Product range

[edit]
ClassRepresentative listingsDocumentation reported
Incretin analoguesSemaglutide, tirzepatide, retatrutideBatch certificate with HPLC trace and mass confirmation, four services per lot
Research peptidesBPC-157, TB-500, growth-hormone secretagoguesCertificate with purity, appearance, water and endotoxin
Custom synthesisSequences quoted individuallyCertificate with mass confirmation and stated analytical conditions
Raw materialsBulk powdersCertificate with purity; specification stated at 98 per cent

References

  1. ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
  2. ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
  3. ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
  4. ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
  5. ^ a b c d e Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.